Tables
Electronic Supplementary Material Table S1. Search strategy and results from each included database
Keywords
AMED
CINAHL
EMBASE
MEDLINE
WoS
ARTHRALGIA/ OR pain
25135
216230
710407
441977
334687
KNEE JOINT/ OR KNEE/ OR
PATELLA/
4166
9449
42923
49222
93798
1 AND 2
929
6526
7409
7494
16216
((((patell* OR femoropatell* OR
femoro-patell* OR retropatell*) AND
(pain OR syndrome OR
dysfunction)))).ti,ab
((((lateral compression OR lateral
facet OR lateral pressure OR odd
facet) AND (pain OR syndrome OR
dysfunction)))).ti,ab
((((chondromalac* OR chondropath*)
AND (knee* OR patell* OR
femoropatell* OR femoro-patell* OR
retropatell*)))).ti,ab
((anterior AND knee AND pain)).ti,ab
549
1199
4801
3904
1004
3
344
27
20
28
32
70
997
822
309
241
535
2500
2038
296
3 OR 4 OR 5 OR 6
1201
7819
12322
10647
16952
predict*.ti,ab
9532
93290
1029853
846964
384763
8 AND 9
63
387
631
484
323
ti = Title, ab = abstract
1
5
Electronic Supplementary Material Table S2 - Quality assessment score allocations for each included study, including subsequent
inter-rater reliability for each item, component and overall score
Study
Witvrouw
et al. [27]
Barton et
al. [20]
Barton et
al. [32]
Crowell et
al. [42]
Iverson et
al. [37]
Pattyn et
al. [25]
Sutlive et
al. [23]
Lesher et
al. [22]
Lan et al.
[30]
Vicenzino
et al. [19]
Natri et al.
[26]
Kannus et
el [31]
Selfe et al.
[29]
Piva et al.
[24]
Wittstein
et al. [28]
1.1
IC
(/2)
1.2
EC
(/2)
1.3
Ad.no
(/4)
1.4
Hom
(/2)
1
Pop
(/10)
2.1
S/D
(/4)
2.2
C/PIA
(/4)
2.3
C/A
(/2)
2
Int
(/10)
3.1
RO
(/4)
3.2
BOA
(/4)
3.3
F/uA
(/2)
3
OM
(/10)
4.1
RD
(/2)
4.2
Dropouts
(/2)
4.3
ITT
(/2)
4.4
SP
(/4)
4
DP/A
(/10)
Total
score
(/40)
TPS
(%)
2
1
2
0
5
4
0
2
6
4
2
1
7
0
2
0
4
6
24
60
2
2
2
0
6
4
0
2
6
4
0
1
5
0
1
0
4
5
22
55
2
2
0
0
4
4
0
2
6
4
0
1
5
0
2
0
4
6
21
53
1
2
1
0
4
4
0
2
6
4
0
0
4
0
2
0
4
6
20
50
2
2
0
0
4
4
0
2
6
4
0
0
4
0
2
0
4
6
20
50
2
1
1
0
4
4
0
1
5
3
2
0
5
0
2
0
4
6
20
50
2
2
0
0
4
4
0
2
6
3
0
0
3
0
2
0
4
6
19
48
2
2
0
0
4
4
0
2
6
3
0
0
3
0
2
0
4
6
19
48
2
2
2
0
6
4
0
0
4
4
0
0
4
0
2
0
2
4
18
45
2
2
0
0
4
4
0
0
4
4
0
1
5
0
1
0
4
5
18
45
2
1
0
0
3
2
0
1
3
4
0
2
6
0
2
0
4
6
18
45
2
1
0
0
3
2
0
1
3
4
0
2
6
0
2
0
4
6
18
45
1
2
2
0
5
2
0
2
4
4
0
1
5
0
1
0
1
2
16
40
2
2
0
0
4
4
0
0
4
3
0
0
3
0
2
0
3
5
16
40
1
1
2
0
4
2
0
0
2
3
0
0
3
0
2
0
4
6
15
38
2
IC=inclusion criteria; EC=exclusion criteria; Ad. no.=adequate number; Hom=homogeneity; Pop=population; S/D=standardized and described; C/PlA=control and placebo
adequate; C/A=co-intervention avoided; Int=interventions; RO=relevant outcome; BOA=blinded outcome assessment; F/uA=follow-up adequate; OM=outcome measures;
RD=randomization described; ITT=intention to treat; SP=statistical procedures; DP/A=data presentation and analysis;TPS = total possible score;
3
4